Cargando…
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
In the context of regenerative medicine and cellular therapies, the treatment under study often targets a less common disease or condition for which recruitment of a large number of research participants at any given site is challenging, if not impossible. One way to overcome this challenge is with...
Autores principales: | Kleiderman, Erika, Boily, Audrey, Hasilo, Craig, Knoppers, Bartha Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225696/ https://www.ncbi.nlm.nih.gov/pubmed/30409192 http://dx.doi.org/10.1186/s13287-018-1055-2 |
Ejemplares similares
-
The ‘serious’ factor in germline modification
por: Kleiderman, Erika, et al.
Publicado: (2019) -
Recruiting Terminally Ill Patients into Non-Therapeutic Oncology Studies: views of Health Professionals
por: Kleiderman, Erika, et al.
Publicado: (2012) -
Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research
por: Bubela, Tania, et al.
Publicado: (2019) -
Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016) -
Overcoming kidney organoid challenges for regenerative medicine
por: Geuens, Thomas, et al.
Publicado: (2020)